Amyloid-β and tau disrupt brain activity, driving early cognitive decline in Alzheimer’s risk

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive decline in older adults at risk of Alzheimer’s disease.

Iontronic technology shows promise in slowing malignant brain tumor growth

When low doses of cancer drugs are administered continuously near malignant brain tumors using so-called iontronic technology, cancer cell growth drastically decreases.

June 19, 2024

How immuno-oncology private equity performed in the pharmaceutical industry in Q2 2023

In value terms, immuno-oncology-related deal activity increased by 319% in Q2 2023 compared with the previous quarter’s total of $19.6m and fell by 53% as

August 1, 2023

Increased Mortality Risk for Young Adults on High Doses of Antipsychotics

Antipsychotic medication-related deaths were rare among children, but young adults on higher doses had a significantly increased risk of death, according to a U.S. national

November 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.